Heyl - Abstract-Bibliothek


Here, professionals and patients will find short summaries (“abstracts”) of scientific publications concerning the agents used in our products. If available, a link to the online-version of the publication will be given.

    11.05.2016 | Category: » Pharma

    Mendoza FA et al. 2016; Severe eosinophilic fasciitis: Comparison of treatment with D-penicillamine plus corticosteroids versus corticosteroids alone; Scand. J. Rheumatol. 45(2):129-34

    Study design: Long term prospective non-randomised trial to compare therapeutic effectiveness of corticosteroids (CS) and CS plus D-penicillamine (D-pen) in patients with … » More

    11.05.2016 | Category: » Pharma

    Brancaleone V et al. 2016; D-penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-gamma-lyase (CSE); Br. J. Pharmacol. 173(9):1556-65

    Study design: D-penicillamine (D-pen) was tested on mouse artoa rings for its vasodilatory effect as a possible cysteine analogue and its effect on H2S … » More

    11.05.2016 | Category: » Antidota

    Karakulak UN et al. 2015; An arrhythmic episode after mercury exposure and successful treatment with chelation therapy: A case report; Anatol. J. Cardiol. 15:586-91

    Study design: This report surveys the case of a female patient presenting weakness of the limbs, malaise, fatigue, atypical chest pain and palpitation due to mercury … » More

    11.05.2016 | Category: » Antidota

    Gaidukov SN et al. 2013; Features of the early neonatal period at children born from mothers with the critical values of mercury in their blood; Mod. Problems Sci. Educat. No. 6

    Study design: This study compared several neonatal parameters of babies born by mothers with critical level of mercury in their blood who were either treated (group 1) with … » More

    04.05.2016 | Category: » Antidota

    Mirzoev EB et al. 2015; The influence of hexacyanoferrate (II) potassium-ferric(III) as a radionuclide sorbent fed at different doses on clinical, hematological and physiological parameters in rats; Agric. Biol. 50(2):237-44

    Study Design: Wistar rats received 0 mg/kg, 11.6 mg/kg, 23.2 mg/kg or 32.4 mg/kg  hexacyanoferrate (II) potassium-ferric (III) orally for 30 days to compare influence on … » More

    29.04.2016 | Category: » Antidota

    Parajuli D et al. 2013; Prussian blue nanoparticles for the enrichment of radioactive cesium in colutions; Waste Management Conference: International collaboration and continuous improvement, Phoenix, AZ (USA), 24-28 Feb 2013

    Study Design: Prussian Blue (PB) nanoparticles in various forms were compared for their ability to adsorb cesium (Cs) from water. Results: Water dispersible nano-PB could … » More

    18.02.2015 | Category: » Antidota

    Langlois DK et al. 2013; Pharmacokinetics and relative bioavailability of D-penicillamine in fasted and nonfasted dogs; J. Vet. Intern. Med. 27(5): 1071-6

    Study Design: Dogs received D-penicillamine (12.5 mg/kg PO) fasted and with food in a randomized, crossover design to test the effect if food on the … » More